Vincerx Pharma, Inc. (VINC) Financials

VINC Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 26.3 million 10.5 million
June 30, 2023 35.3 million 11.1 million
March 31, 2023 47.4 million 13.0 million
Dec. 31, 2022 59.3 million 11.6 million

VINC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -6.6 million 1.3 million
June 30, 2023 -12.7 million 694000
March 31, 2023 -13.1 million 1.1 million
Dec. 31, 2022 -13.8 million 1.5 million

VINC Net Income

No data available :(

VINC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 20.8 million - 2.8 million
June 30, 2023 27.4 million - 3.0 million
March 31, 2023 39.8 million - 3.3 million
Dec. 31, 2022 52.5 million - 3.4 million

VINC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 21.3 million
June 30, 2023 21.3 million
March 31, 2023 21.2 million
Dec. 31, 2022 21.1 million

VINC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 6.8 million 3.5 million -
June 30, 2023 - 7.9 million 3.8 million -
March 31, 2023 - 10.6 million 4.5 million -
Dec. 31, 2022 - 11.4 million 4.1 million -

VINC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 254000
June 30, 2023 - 249000
March 31, 2023 - 154000
Dec. 31, 2022 - 241000

VINC

Price: $0.01

52 week price:
0.00
1.43

Earnings Per Share: -5.79 USD

P/E Ratio: -0.01

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 181372

Market Capitalization: 66475

Links: